CN105154578A - Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method - Google Patents

Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method Download PDF

Info

Publication number
CN105154578A
CN105154578A CN201510702371.9A CN201510702371A CN105154578A CN 105154578 A CN105154578 A CN 105154578A CN 201510702371 A CN201510702371 A CN 201510702371A CN 105154578 A CN105154578 A CN 105154578A
Authority
CN
China
Prior art keywords
fluorescent
sample
alpha
test kit
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510702371.9A
Other languages
Chinese (zh)
Inventor
翁勋锦
叶学和
龙驹
孙雷
庞婉容
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINZHOU MATERNAL AND CHILD HEALTH HOSPITAL
Original Assignee
QINZHOU MATERNAL AND CHILD HEALTH HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINZHOU MATERNAL AND CHILD HEALTH HOSPITAL filed Critical QINZHOU MATERNAL AND CHILD HEALTH HOSPITAL
Priority to CN201510702371.9A priority Critical patent/CN105154578A/en
Publication of CN105154578A publication Critical patent/CN105154578A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on a fluorescent hydrolysis probe method. The kit comprises amplification primers and a fluorescent probe, wherein the amplification primers are a pair of primers 21.9-F and 21.9-R capable of amplifying characteristics sequences of -alpha 21.9 alleles in alpha-globin gene clusters, the 21.9-F is 5'-GGAGCTTTTCCTTCCCTGGAACG-3', the 21.9-R is 5'-TGTGGTTGGAGAATGGAGGTGG-3', the fluorescent probe is a fluorescent probe 21.9-Prob for specific detection of 21.9-F and 21.9-R amplification products, and the specific 21.9-Prob is 5'-6-FAM-CTGGGGAAGGGTGGGTGGGAATAACAGC BHQ-1-3'.

Description

Based on the rapid detection-α of fluorescent hydrolysis probe method 21.9the allelic test kit of absence type thalassemia
Technical field
The present invention relates to technical field of medical detection, be specifically related to a kind of rapid detection-α based on fluorescent hydrolysis probe method 21.9the allelic test kit of absence type thalassemia.
Background technology
Thalassemia also claims globin dyssynthesis anaemia, is called for short poor.Thalassemia is one of modal monogenic inheritance disease in Guangxi province, and the poor kind in common ground has α-ground poor poor with β-ground.In Chinese population, what the poor genotype in α-ground was common is absence type-- sEA,-α 3 . 7with-α 4 . 2.2013, healthcare hospital for women & children of Qinzhou City detected the rarely poor genotype of a kind of called after ' the poor absence type in Qiezhou type α ground ', be the disappearance of the DNA sequence dna of one section of 21.9kb in alpha globin gene bunch (NG_000006.1) due to this genotypic the Molecular Biology Mechanism, be therefore abbreviated as-α 21.9(LongJ, YanS, LaoK, PangW, YeX, SunL.Thediagnosisandmolecularanalysisofanovel21.9kbdelet ion (Qinzhoutypedeletion) causing α+thalassemia.BloodCellsMolDis.2014; 52 (4): 225-9.).In routine duties, applicant finds that this genotype has certain distribution probability in Guangxi, and genotypicly to fail to pinpoint a disease in diagnosis for reducing this, need set up one can quick-α 21.9allelic detection kit.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of rapid detection-α based on fluorescent hydrolysis probe method 21.9the allelic test kit of absence type thalassemia.Adopt this test kit can realize single tube single and react-α 21.9the allelic detection of absence type thalassemia, and there is susceptibility highly, stability and accuracy, and higher specificity.
Rapid detection-α based on fluorescent hydrolysis probe method of the present invention 21.9the allelic test kit of absence type thalassemia, comprises amplimer and fluorescent probe, it is characterized in that:
Described amplimer is :-α in the α-globin gene cluster that can increase for a pair 21.9primer 2 1.9-F and 21.9-R of allelic characteristic sequence, wherein:
21.9-F:5’-GGAGCTTTTCCTTCCCTGGAACG-3’;
21.9-R:5’-TGTGGTTGGAGAATGGAGGTGG-3’;
Described fluorescent probe is the fluorescent probe 21.9-Prob of specific detection 21.9-F and 21.9-R amplified production, is specially:
21.9-Prob:5’-6-FAM-CTGGGGAAGGGTGGGTGGGAATAACAGC-BHQ-1-3’。
In fluorescent probe in mentioned reagent box, FAM refers to Fluoresceincarboxylic acid, and BHQ-1 refers to fluorescent quenching group.
Rapid detection-α based on fluorescent hydrolysis probe method of the present invention 21.9the allelic test kit of absence type thalassemia, also comprises component conventional and necessary in some available reagent boxes, as damping fluid, enzyme liquid, MgCl 2and dNTP.Particularly, enzyme liquid is Taq polymerase systems, comprises the warm start enzyme system etc. that can be used for hydrolysis probes method; Described damping fluid is conventional PCR damping fluid; When enzyme liquid select to adopt health for produce in century GoldStarTaqDNAPolymerase time, damping fluid is then preferably the damping fluid supporting with GoldStarTaqDNAPolymerase.
Adopt mentioned reagent box rapid detection-α 21.9the allelic method of absence type thalassemia comprises the following steps:
1) extracting sample genomic dna, prepares DNA profiling;
2) prepare reaction system, be specially:
By primer 2 1.9-F and 21.9-R, probe 21.9-Prob, and PCR damping fluid, enzyme liquid, MgCl 2, dNTP, water and DNA profiling be mixed with reaction system;
3) pattern detection: respectively the reaction system of preparation is carried out pcr amplification, records the cycle index Cq (size of Cq value can reflect institute's detection template number number) experienced when fluorescent signal in each PCR reaction tubes arrives the thresholding of setting;
4) data analysis and result judge: the analysis software result of determination carried according to real-time fluorescence quantitative PCR instrument, when FAM passage has Cq value reading, then represents that this sample carries-α 21.9allelotrope; When FAM passage does not have Cq value reading, then represent that this sample does not carry-α 21.9allelotrope.
The step 1 of aforesaid method) in, adopt existing ordinary method to prepare DNA profiling.
The step 2 of aforesaid method) in, in reaction system, the concentration of each component is preferably: DNA:1 ~ 3ng/ μ L to be detected; Each primer: 0.3 ~ 0.5 μm of ol/L; Concentration and probe concentration is 0.3 ~ 0.5 μm of ol/L; DNA profiling: 20 ~ 200ng; Magnesium ion: 1.5 ~ 1.9mmol/L; The final volume of reaction system is preferably 20 μ L.
The step 3 of aforesaid method) in, pcr amplification condition is: 95 DEG C of denaturations 8 ~ 12 minutes, then 95 DEG C 15 ~ 30 seconds, 60 DEG C of annealing 50 ~ 70 seconds, 39 ~ 49 circulations, in 60 DEG C of annealing steps end collection fluorescent signals.
Compared with prior art, feature of the present invention is:
1, test kit of the present invention can realize the reaction of single tube single and directly complete-α 21.9allelic detection; P-α 21.9allelotrope detects susceptibility, stability and the accuracy with height, and higher specificity.
2, test kit of the present invention is applied to fluorescent hydrolysis probe method detection-α 21.9during allelotrope, without the need to open pipe operation, reduce the possibility that laboratory PCR primer is polluted to the utmost.
3, adopt the experimental program of fluorescent hydrolysis probe fewer than existing additive method required time, not high to equipment requirements.
Accompanying drawing explanation
Fig. 1 is the amplification curve of 1# sample in the embodiment of the present invention 1;
Fig. 2 is the amplification curve of 2# sample in the embodiment of the present invention 1.
Embodiment
Below in conjunction with specific embodiment, the present invention is described in further detail, and to understand content of the present invention better, but the present invention is not limited to following examples.
Embodiment 1: adopt the detected result of test kit of the present invention in known type sample
1, the composition of test kit:
-α in the α-globin gene cluster that can increase 21.9primer pair 21.9-F and 21.9-R of allelic characteristic sequence:
21.9-F:5’-GGAGCTTTTCCTTCCCTGGAACG-3’(SEQIDNO:1);
21.9-R:5’-TGTGGTTGGAGAATGGAGGTGG-3’(SEQIDNO:2);
The fluorescent probe 21.9-Prob of specific detection 21.9-F and 21.9-R amplified production is:
21.9-Prob:5’-6-FAM-CTGGGGAAGGGTGGGTGGGAATAACAGC-BHQ-1-3’(SEQIDNO:3)。
Other moiety:
GoldStarTaqDNAPolymerase, be all century purchased from health with the supporting damping fluid of GoldStarTaqDNAPolymerase and dNTPs, MgCl 2purchased from LifeTechnology.
PCR reaction system is prepared by following table 1:
Table 1:(mM represents mmol/L, μM expression μm ol/L)
2, implementation method:
It is Bio-Rad real time thermocycler CFX96 that PCR reacts instrument.PCR response procedures is: 95 DEG C of denaturations 10 minutes, then 95 DEG C 15 seconds, 60 DEG C of annealing 60 seconds, 40 circulations, in 60 DEG C of annealing steps end collection fluorescent signals.
Sample process: adopt Lab-AidDNAminiextractionkid (Bio-V, Xiamen) test kit extracting DNA, be diluted to 20 ~ 200ng/ μ L with distilled water for subsequent use.DNA sample also can adopt other conventional DNA extraction method to extract.
Pattern detection: detect the known type sample to be checked (being called for short 1# sample) determined by ordinary method by 1 part; and 1 part of normal genotype (α α/α α; N/N) sample (being called for short 2# sample); according to above-mentioned reaction system and response procedures; augmentation detection is carried out, record Cq value on quantitative real time PCR Instrument.
3, samples sources: all sample standard deviations source conventional Gap-PCR technology of hanging oneself determines genotypic DNA sample.
4, data analysis and result judge: the analysis software sentence read result carried according to real-time fluorescence quantitative PCR instrument.If FAM passage has Cq value reading, then represent that this sample carries-α 21.9allelotrope; If FAM passage does not have Cq value reading, then represent that this sample does not carry-α 21.9allelotrope.Analyze after testing, the FAM passage of 1# sample has Cq value reading (as shown in Figure 1, Cq value reading as shown in Table 2 for amplification curve), represents that 1# sample carries-α 21.9allelotrope; The FAM passage of 2# sample does not have Cq value (as shown in Figure 2, Cq value reading as shown in Table 3 for spectrogram), represents that 2# sample does not carry-α 21.9allelotrope.
Table 2:
Table 3:
Visible, adopt test kit of the present invention carry out-α 21.9when absence type thalassemia allelotrope detects, result is accurate; And wild-type sample is without non-specific amplification, there is higher specificity.
Embodiment 2: the Detection results of test kit of the present invention in random gene type sample.
1, the composition of test kit:
With embodiment 1.
2, implementation method:
With embodiment 1.
3, samples sources:
Sample is 12 routine random samples (being provided by healthcare hospital for women & children of Qinzhou City), is diluted to 20 ~ 200ng, as sample to be checked with distilled water), and through the 2 routine wild-type samples that Gap-PCR verifies, 2 routine positive sample.
4, data analysis and result judge:
According to the analysis software sentence read result that real-time fluorescence quantitative PCR instrument carries.If FAM passage has Cq value reading, then represent that this sample carries-α 21.9allelotrope; If FAM passage does not have Cq value reading, then represent that this sample does not carry-α 21.9allelotrope.Result as described in Table 4.
Table 4:
Note: NegCtrl=negative control in sample type, PosCtrl=positive control, Unkn=unknown sample type, in detected result, N/A=is without Cq value.
Result shows, and wild-type sample does not detect Cq value, and positive sample detects Cq value, detects an example-α in random sample 21.9allelotrope.

Claims (2)

1. based on the rapid detection-α of fluorescent hydrolysis probe method 21.9the allelic test kit of absence type thalassemia, comprises amplimer and fluorescent probe, it is characterized in that:
Described amplimer is :-α in the α-globin gene cluster that can increase for a pair 21.9primer 2 1.9-F and 21.9-R of allelic characteristic sequence, wherein:
21.9-F:5’-GGAGCTTTTCCTTCCCTGGAACG-3’;
21.9-R:5’-TGTGGTTGGAGAATGGAGGTGG-3’;
Described fluorescent probe is the fluorescent probe 21.9-Prob of specific detection 21.9-F and 21.9-R amplified production, is specially:
21.9-Prob:5’-6-FAM-CTGGGGAAGGGTGGGTGGGAATAACAGC-BHQ-1-3’。
2. test kit according to claim 1, is characterized in that: described test kit also comprises damping fluid, enzyme liquid, MgCl 2and dNTP.
CN201510702371.9A 2015-10-26 2015-10-26 Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method Pending CN105154578A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510702371.9A CN105154578A (en) 2015-10-26 2015-10-26 Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510702371.9A CN105154578A (en) 2015-10-26 2015-10-26 Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method

Publications (1)

Publication Number Publication Date
CN105154578A true CN105154578A (en) 2015-12-16

Family

ID=54795619

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510702371.9A Pending CN105154578A (en) 2015-10-26 2015-10-26 Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method

Country Status (1)

Country Link
CN (1) CN105154578A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105713975A (en) * 2016-03-29 2016-06-29 钦州市妇幼保健院 Kit for rapidly detecting -alpha<2.4> deficiency type alpha thalassaemia alleles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JU LONG等: "The diagnosis and molecular analysis of a novel 21.9kb deletion(Qinzhou type deletion) causing α+ thalassemia", 《BLOOD CELLS, MOLECULES AND DISEASES》 *
陈碧艳等: "双重TaqMan 荧光定量PCR 在β-地中海贫血产前诊断中的应用", 《广西医学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105713975A (en) * 2016-03-29 2016-06-29 钦州市妇幼保健院 Kit for rapidly detecting -alpha<2.4> deficiency type alpha thalassaemia alleles

Similar Documents

Publication Publication Date Title
CN104178573B (en) For detecting test kit and the using method thereof of common deletion type α-thalassemia
CN106636390A (en) Gene methylation detection method, detection kit and application thereof
CN104141014A (en) Kit for rapidly detecting common deletion type alpha-thalassemia and use method of kit
Viltrop et al. Comparison of DNA extraction methods for multiplex polymerase chain reaction
CN112739833A (en) Primer pair, probe and kit for detecting SARS-CoV-2 by utilizing nested RPA technology and application thereof
CN107254543B (en) PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome
CN108949961A (en) For detecting kit and its screening of adenovirus pneumonia
CN105176995A (en) Hydrolysis probe method based kit capable of simultaneously detecting deletion -alpha&lt;21.9&gt; and alpha2 variation of thalassemia
CN105154575A (en) Kit for quickly detecting sinotype deletional thalassemia based on hydrolysis probe method
CN105154533B (en) Diagnose the miRNA combination and its kit of early liver cancer
CN105177152B (en) Detect the method and primer of HLA-B*51 allele
CN103937806A (en) Rh blood group DEL phenotype RHD838&gt;A allele and detection method thereof
CN104087672A (en) Kit for quickly detecting number of human chromosomes 21 by multiplex real-time fluorescence quantitative PCR (polymerase chain reaction) technique
CN105154578A (en) Kit for quickly detecting -alpha 21.9 deletional thalassemia alleles based on fluorescent hydrolysis probe method
CN105177167A (en) Kit for quickly detecting HPFH deletion type thalassemia based on hydrolysis probe method
CN105176996A (en) Taqman-based kit for quickly detecting Mediterranean anemia Thailand deletion
CN104087671A (en) Kit used for detecting number of human chromosomes 21
CN105154580A (en) Kit for quickly detecting rare deletional thalassemia based on hydrolysis probe method
JP6612509B2 (en) Method, recording medium and determination device for assisting prognosis of colorectal cancer
CN110951857B (en) Method and kit for noninvasively detecting fetal trisomy 21, 18 and 13 syndrome based on digital PCR (polymerase chain reaction)
CN105713975A (en) Kit for rapidly detecting -alpha&lt;2.4&gt; deficiency type alpha thalassaemia alleles
CN105154579A (en) Reagent kit for rapidly detecting -alpha21.9 deletion type thalassemia alleles
CN105154574A (en) Kit for quickly detecting rare deletional thalassemia based on solubility curve method
CN105154577A (en) Reagent kit for rapidly detecting alpha2 mutant alleles
CN105969842A (en) Glu504lys detection genotyping kit based on AllGlo probe and genotyping method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151216